Raymond Dwek
Director/Board Member at UNITED THERAPEUTICS CORPORATION
Net worth: 402 010 $ as of 2024-03-30
Profile
Raymond Allen Dwek is the founder of Oxford GlycoSciences Plc, which was founded in 1988.
He is currently an Independent Director at United Therapeutics Corp.
since 2002.
Mr. Dwek's former jobs include Chairman-Technology & Society at The Library of Congress, Director-Emeritus at Oxford Glycobiology Institute from 1988 to 2021, Professor & Head-Biochemistry Department at the University of Oxford from 1966 to 2009, and President at Institute of Biology from 2008 to 2010.
Mr. Dwek's education includes undergraduate and graduate degrees from the University of Oxford.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-14 | 1,750 ( 0.00% ) | 402 010 $ | 2024-03-30 |
Raymond Dwek active positions
Companies | Position | Start |
---|---|---|
UNITED THERAPEUTICS CORPORATION | Director/Board Member | 2001-12-31 |
Former positions of Raymond Dwek
Companies | Position | End |
---|---|---|
Oxford Glycobiology Institute | Director/Board Member | 2020-12-31 |
Institute of Biology | President | 2009-12-31 |
University of Oxford | Corporate Officer/Principal | 2008-12-31 |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Director/Board Member | 2002-12-31 |
The Library of Congress (District of Columbia) | Corporate Officer/Principal | - |
Training of Raymond Dwek
University of Oxford | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
Private companies | 3 |
---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
The Library of Congress (District of Columbia) | Government |
Institute of Biology |
- Stock Market
- Insiders
- Raymond Dwek